SUN reported an EPS of LKR 0.45 (+72.6% YoY) for 4Q FY25 resulting from a PATMI of LKR 877.1mn supported by EBIT margin expansion (13.4% vs previous 9.7%). Group turnover grew by 7.9% YoY to LKR 14.1bn driven by continued growth in the Healthcare segment despite a contraction from the Consumer segment which stemmed from Confectionary and Tea Exports. A 74% YoY reduction in net finance costs (to LKR 79mn) further improved SUN’s bottomline. We continue to remain bullish on SUN in the medium to long term, driven by robust Healthcare segment performance. Favourable macro conditions will support higher discretionary spending and drive the Consumer segment recovery while Agribusiness is expected to yield steady returns positioning SUN for long term growth. We maintain our BUY call with a TP of LKR 30.00.